What We Do

We serve each client with deep experience and a diversity of perspectives.

Name: Faber Daeufer & Itrato
Price range: $

We serve a variety of different client groups and work on varying projects for over 2,000 companies, investors, research institutions, and other participants in the life sciences and high-tech fields.

Vitals monitor — Companies Developing and Commercializing Medical Devices

Learn More

Shipping containers — CMC/Supply Chain Agreements

Learn More

Two Buildings with Trees out Front — Academic Research Institutions & Foundations

Learn More

Woman putting coin into piggy bank — Venture Capital & Private Equity Investors

Learn More

Code on computer — Software, SaaS, Database Services & IT Devices

Learn More

Client Groups We Serve

Person holding petri dish — At Faber, our integrated team of lawyers and contracts specialists have helped our clients launch hundreds of clinical trials, and collectively they’ve worked on over 10,000 CTAs.

Pexels markus spiske 2004161 2022 11 01 201749 qflt — Increasingly, the collection and exploitation of large data sets, and the leverage of complex software systems (including machine learning, organs-on-a-chip, and laboratory high-throughput automation) are changing pharmaceutical R&D.

Academic Research Institutions & Foundations

Not-for-profit research institutions are strong sources and drivers of innovation. And collaborating with universities, research hospitals and foundations is an increasingly important way for companies to accelerate value creation – whether the field is life science, healthcare IT, medical devices or engineering technology.

Companies Developing and Commercializing Medical Devices, Diagnostics, & Laboratory Equipment

At Faber, we’ve represented 2,000+ clients in life sciences, healthcare IT, medical devices and engineering technology.

Companies Developing and Commercializing Pharmaceuticals

At Faber, our integrated team of lawyers and contracts specialists have helped our clients launch hundreds of clinical trials, and collectively they’ve worked on over 10,000 CTAs.

Software, SaaS, Database Services & IT Devices

Increasingly, the collection and exploitation of large data sets, and the leverage of complex software systems (including machine learning, organs-on-a-chip, and laboratory high-throughput automation) are changing pharmaceutical R&D.

Venture Capital & Private Equity Investors

Private capital drives the translation of new learnings in basic science to the development of products that meet medical needs. Notwithstanding the proliferation of “industry standard” venture financing documents, crafting the financial and governance terms of a financing to align the interests of scientific founders and investors remains an art.